How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
Hormonal changes during perimenopause and menopause influence insulin sensitivity, appetite regulation, and medication tolerance
Digital z-stacks were collected with a Zeiss LSM 880 confocal microscope (20x and 63x)
Ozempic, Wegovy, Zepbound), estimated copay and/or out-of-pocket costs, the latest drug supply data, and information about options available through Ro
A well-formulated retinol or peptide serum could deliver similar (or better) results over time
McElroy SL et al